IP Verse

Bendamustine Cyclopolysaccharide Compositions - EP2792369

The patent EP2792369 was granted to Softkemo Pharma on Apr 18, 2018. The application was originally filed on Feb 24, 2010 under application number EP14177306A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2792369

SOFTKEMO PHARMA
Application Number
EP14177306A
Filing Date
Feb 24, 2010
Status
Opposition Rejected
Jul 10, 2020
Grant Date
Apr 18, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

INTAS PHARMACEUTICALSJan 17, 2019ACCORD HEALTHCAREADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONCN101606934
OPPOSITIONDD159289
OPPOSITIONUS2002058634
OPPOSITIONUS2006159713
SEARCHCN101606934

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- VINOGRADOV S. V. ET AL., BIOCONJUGATE CHEM., (1998), vol. 9, pages 805 - 812-
OPPOSITION- DAVID Q. MA et al., "Comparative effects of (SBE) 7m-beta- CD and HP-,beta- CD on the stability of two anti-neoplastic agents, melphalan and carmustine", Journal of Pharmaceutical Sciences, (20000200), vol. 89, no. 2, pages 275 - 287, XP055551758-
OPPOSITION- DAVID Q. MA et al., "New injectable melphalan formulations utilizing (SBE)7m-beta- CD or HP-,beta- CD", International Journal of Pharmaceutics, (19991105), vol. 189, no. 2, pages 227 - 234, XP001127440
OPPOSITION- RAJEWSKI et al., "Pharmaceutical application of Cyclodextrin. 2. In vivo drug delivery (Review Article", Journal of Pharmaceutical Sciences, (19961100), vol. 85, no. 11, pages 1142 - 1169, XP000629515
OPPOSITION- MEDLICOTT et al., "Comparison of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions on cultured endothelial cells (HUV- EC", Journal of Pharmaceutical Sciences, (19980900), vol. 87, no. 9, pages 1138 - 1143, XP055551762

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents